Latest Development in MS Treatment and Research
from Picking Our Brain with Shepherd Center Hosted by Shepherd Center
Researchers are reporting exciting work under way to develop new treatments for multiple sclerosis. A number of clinical trials are under way at Shepherd Center and elsewhere. The U.S. Food and Drug Administration (FDA) has approved Plegridy™ (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis (RMS). Clinical trials show the drug reduces relapses, disability progression and brain lesions. MS management can be divided into three areas: relapse treatment, symptom management and disease modification. Listen in as Ben Thrower, M.D., discusses the latest developments in MS management at Shepherd Center.
Embed this episode
No transcript yet.